{"version":"1.0","type":"link","title":"Updates in US Food and Drug Administration approvals for poly-ADP-ribose polymerase inhibitors in Ovarian Cancer: A society of gynecologic oncology clinical practice review.","author_name":"Washington C 외","author_url":"https://prs-insight.online/author/Washington%20C","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/89589","thumbnail_width":1200,"thumbnail_height":630}